Tag: TeVido Biodevices

Six Women Run Tech Startups to Watch in Austin

Laura Bosworth, co-founder of TeVido Biodevices, photo by John Davidson.

Laura Bosworth, co-founder of TeVido Biodevices, photo by John Davidson.

Reporter with Silicon Hills News

The stats don’t bode well for women-run tech startups nationwide. Less than 3 percent of venture-backed startups have a woman as a CEO.

But things are changing. Groups like Women@Austin, Women Who Code and Women in Technology are shining a spotlight on female tech entrepreneurs locally. And crowdfunding, bootstrapping, government grants and angel investors are helping more women entrepreneurs to launch and grow their ventures.

In fact, Nerd Wallet named Austin as one of the top 10 places for female entrepreneurs. And here’s six women run technology startups in Austin to keep an eye on as they expand their ventures:

Spot on Sciences – Dr. Jeanette Hill founded her medical device startup in 2010. It creates a blood collection device called HemaSpot. It lets people take a blood sample safely, securely and easily from a remote location and send it to their doctor for analysis. The company is bootstrapped but has received about $2 million in research grants.

TeVido Biodevices – Laura Bosworth is the co-founder and CEO of this life sciences startup that is making nipples from human cells using 3D printers. The company recently completed a successful crowd-funding campaign and received a Small Business Innovation Research grant from the National Cancer Institute of the National Institute of Health and a grant from the National Science Foundation.

Fashion Metric – Daina Linton is a CEO and co-founder of the startup that acts as a virtual tailor. Her husband, Morgan Linton, is also a co-founder. They founded the company in Los Angeles and moved to Austin last year to participate in Techstars. They decided to permanently relocate and they recently closed on $1 million in financing. The company makes software and has a special algorithm to help people find the right-sized clothes online.

Testlio – Kristel Viidik is one of two co-founders of this startup that is a community of test engineers that test mobile apps to find bugs. The company, originally from Estonia, relocated to Austin to participate in the first Austin Techstars program in 2013. The company has raised $1 million.

Wisegate – CEO Sara Gates founded the company in 2010 and has since raised nearly $9 million. Wisegate has created a platform for IT leaders to interact and share information.

Double Line Partners – Zeynep Young founded the company in 2009 and has since grown it to $20 million in revenue and 120 employees. The startup makes software, data system dashboards and other tools to help schools improve the performance of their students in grades K-12.

TeVido BioDevices Launches IndieGoGo Crowdfunding Campaign

Laura-Bosworth-199x300TeVido BioDevices, which prints 3D nipples crafted from human cells, has launched a crowdfunding IndieGoGo campaign to raise $35,000.

The Austin-based company recently received a Small Business Innovative Research grant from the National Cancer Institute of the National Institute of Health and a grant from the National Science Foundation for total funding worth $900,000. It is also a graduate of the Jon Brumley Texas Ventures Lab at the University of Texas at Austin.

TeVido is raising the money to cover the costs of filing for patents on its technology and methods. So far, the company has raised $8,428 or 24 percent of its goal. It has 50 days left to meet its funding goal.

“Every dollar counts,” Laura Bosworth, the company’s CEO and co-founder said at the Venture Expo Fall program. She presented an update on her company as an alumni presenter.

“Globally nearly 1.5 million women receive a diagnosis of breast cancer each year, and in the United States it is estimated that forty percent of the nearly 300,000 women diagnosed undergo mastectomy or full removal of the breast tissue as part of their cancer treatment regime,” according to TeVido. “Approximately one-third of all mastectomy patients will undergo breast reconstruction, with the final step in the process involving the nipple areola complex (NAC). Unfortunately, results of currently available NAC reconstruction techniques are unpredictable and studies highlight that patients with loss of the nipple and areola continue to experience psychological distress long after the overall breast shape has been reconstructed. Recreation of the nipple-areola complex has a high correlation with overall patient satisfaction and acceptance of body image.”

TeVido’s patent pending technology called Cellatier uses 3D bioprinting to build custom nipple grafts for patients undergoing reconstructive surgery.

Silicon Hills News did this profile of TeVido Biodevices earlier this year.

Printing the Human Body

Reporter with Silicon Hills News

Photos courtesy of UTEP News Service - Aurelio Hernandez

Photos courtesy of UTEP News Service – Aurelio Hernandez

“Our first product will be the nipple,” says Laura Bosworth. And the CEO and co-founder of TeVido BioDevices isn’t talking about a silicon attachment for a baby bottle, her startup aims to 3-D print human tissue.

It sounds like the stuff of science fiction, but making it a reality may not be far off: Bosworth estimated that if TeVido secured the necessary funding ($7-8 million), they could be ready for clinical trials in as little as two years.

Bosworth started TeVido with Dr. Thomas Boland who is one of the foremost researchers of live-cell tissue printing. Boland is the inventor of a patent for inkjet tissue printing. He first tried modifying an inkjet printer to print with human cells in 2000, when he was working at Clemson University. He is now based at the University of Texas at El Paso where he is the director of biomedical engineering.

Laura BosworthBosworth retired in 2008 after spending a decade each at Dell and IBM. An engineer by training, Bosworth worked in manufacturing engineering, corporate strategy, product development and marketing over the course of her career. Finding that the leisure life was not for her, Bosworth began working with startups in 2009 at the suggestion of one of her old mentors from Dell.

The dean of engineering at UTEP called on her to advise their commercialization office. Volunteering at the university is how Bosworth met Boland and learned about his work. She was immediately enthralled.

“This is so amazing, and has the potential to really change certain aspects of medicine,” she said. Bosworth volunteered to take on the CEO role and help bring bioprinting to market.

TeVido was founded in 2011. After going through a couple different ideas and investigating the market, they decided to focus on nipple-areola reconstruction. Structurally, nipples are fairly small and simple, comprised mainly of fat and skin cells. The trick with bioprinting anything thicker than .1mm layer of skin is that it needs a vascular structure to deliver oxygen to the tissue, otherwise it will die. Bosworth says their technology is unique in that it has the capability to deliver that capillary structure.

Serial entrepreneur Scott Collins, who has a PhD in biomedical engineering, is the  chief technology officer

Serial entrepreneur Scott Collins, who has a PhD in biomedical engineering, is the chief technology officer

In 2012, TeVido brought on serial entrepreneur Scott Collins who has a PhD in biomedical engineering to be chief technology officer. Boland remains based at UTEP, while Collins oversees the company’s ongoing research and development. From July forward, TeVido is targeted to move into the Texas Life Sciences Collaboration Center in Georgetown, though the relocation depends on securing funding. Collins says one of his goals is to someday bioprint a human heart. But it’s not only the relative simplicity of nipples that make them a good starting point, there’s a clear need for better solutions in post-cancer breast reconstruction.

“The plastic surgeons we’ve talked to see the need for this,” Collins said.

Presently, there are several imperfect options for approximating a nipple in reconstruction surgery. A common one is to create the protrusion by sewing skin together and tattooing it for color, but this solution very often does not last.

Bosworth recounted interviewing one woman who’d had 15 surgeries over seven years. “They don’t look great,” the woman told her, and as for the nipples, “flattened and faded.” There is a substantial amount of research about the trauma and distress of losing nipples to cancer. For many women, reconstructed nipples are an important part of the psychological healing process.

Presently, funding is a major challenge. TeVido has received less than $1 million to date, mostly through government grants, and Bosworth has heard a lot of “you’re too early” and “it’s too risky.” “People don’t want to fund you until you’re in human tests,” she said, but there is a lot of expensive work to be done before reaching that stage. In the best-case scenario, their product could be on the market in five years, but it may take much longer. TeVido applied for a $750,000 National Science Foundation grant in January. If they get it, they’ll have the opportunity to apply for further funding.

inkjet printer photo (UTEP News Service – Aurelio Hernandez)One of the reasons 3-D printing human tissues makes sense is that the source cells will come from the patient, and the printing process will be tailored to her precise dimensions. How TeVido’s printing will likely work is the plastic surgeon who is performing breast reconstruction will take a sample of skin and fat from the patient and send it to TeVido’s labs. The doctor will coordinate his surgery, scheduling with TeVido so that the nipple is printed and delivered at the right time. Since TeVido will be using the patient’s own cells, they are optimistic about the longevity of their product, especially in comparison to the nipple reconstructions that are on the market now.

Perhaps in a couple decades, printers like TeVido’s will be producing full, complex human organs and save some people from lingering on a lengthy list awaiting organ donors. Bioprinting solutions may one day supersede mechanical ones because bioprinted human tissues will grow with the patient, unlike synthetic solutions, which sometimes need to be replaced as the patient’s body grows and changes.

If TeVido is successful, it could clear the path for other 3-D printed, human-tissue products.

“Sometimes people say, ‘why did you pick something so hard?'” Bosworth says. “I tell them, ‘it picked me.'”

Editor’s Note: Laura Bosworth is one of the featured speakers at Voice & Exit on Saturday at Austin Music Hall. The company also recently won TechCrunch’s pitch off contest in Austin and it will present at TechCrunch Demo in the fall.

© 2024 SiliconHills

Theme by Anders NorenUp ↑